BC
BIIB icon

Banced Corp’s Biogen BIIB Stock Holding History

Banced Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-583
Closed -$235K – 123
2015
Q2 		$235K Sell
583
-64
-10% -$25.7K 0.32% 126
2015
Q1 		$273K Sell
647
-172
-21% -$67.8K 0.39% 109
2014
Q4 		$278K Sell
819
-760
-48% -$246K 0.3% 140
2014
Q3 		$522K Sell
1,579
-163
-9% -$53.7K 0.6% 59
2014
Q2 		$549K Sell
1,742
-842
-33% -$253K 0.66% 45
2014
Q1 		$790K Sell
2,584
-190
-7% -$60.3K 0.82% 27
2013
Q4 		$776K Sell
2,774
-292
-10% -$75.5K 0.78% 37
2013
Q3 		$738K Buy
3,066
+411
+15% +$92K 0.74% 41
2013
Q2 		$571K Buy
+2,655
New +$567K 0.59% 65

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Banced Corp's BIIB Position: Q3 2015 in Review

Banced Corp sold out of Biogen (BIIB) in Q3 2015, closing a stake of 583 shares — an estimated $235K sold.

Banced Corp first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $790K in Q1 2014. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Banced Corp reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Banced Corp sold 583 Biogen shares in Q3 2015, an estimated $235K.
  • Banced Corp first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Banced Corp's Biogen position peaked at $790K in Q1 2014.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Banced Corp's 13F filing for Q3 2015, filed 16 Oct 2015.